This study revealed that Cynarine could significantly reduce the fat deposition ability of NAFLD model cells, which may be closely related to the effective regulation of AKT1 and MAPK1 expression by Cynarine. This evidence concerns the gene MAPK1 and metabolic dysfunction-associated steatotic liver disease.